Therapeutic Drug Monitoring in Child and Adolescent Psychiatry
Status:
Completed
Trial end date:
2019-03-05
Target enrollment:
Participant gender:
Summary
The investigators aim to analyse in adolescents with mental illness effectiveness, side
effects, and serum level concentrations of antipsychotics (olanzapine and aripiprazole),
antidepressants (Duloxetine, Atomoxetine) by means of "Therapeutic Drug Monitoring" (TDM) in
order to optimize dosage - effect relations and minimize unwanted side effects.